Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trial

作者：Magdalena E. Sobieszczyk, Sharon Mannheimer, Carmen A. Paez, Chenchen Yu, Theresa Gamble, Deborah Theodore, Wairimu Chege, Margaret Yacovone, Brett Hanscom, Jack Heptinstall, Kelly E. Seaton, Lily Zhang, Maurine D. Miner, Amanda Eaton, Joshua A. Weiner, Kenneth H. Mayer, Spyros A. Kalams, Kathryn E. Stephenson, Boris Jülg, Marina Caskey, Michel C. Nussenzweig, Lúcio Gama, Dan H. Barouch, Margaret E. Ackerman, Georgia D. Tomaras, Yunda Huang, David C. Montefiori · 发表于：The Lancet HIV · 年份：2023 · DOI：10.1016/s2352-3018(23)00140-6 · 被引用次数：33 · 研究领域：HIV Research and Treatment、HIV/AIDS drug development and treatment、HIV/AIDS Research and Interventions